For Healthcare Professionals

BAROSTIM NEO System in the Treatment of Heart Failure

clipboard-pencil

About the study

The purpose of this portion of study NCT01471860 is to assess the long-term safety and efficacy of the BAROSTIM NEO System in Canadian study participants implanted with the device.
user-3

Who can take part

You may be eligible to participate in the study if you meet the following criteria:

INCLUSION CRITERIA

  1. Actively participating in the Neo Randomized Heart Failure Study.
  2. Have signed a revised approved informed consent form for continued participation in this study.

EXCLUSION CRITERIA

  1. Treating physician decision that the subject should not continue with therapy.
pin location

Study Locations

Enter your ZIP code/Postal code/PIN code to locate study sites near you:

How to Apply


Contact the study center to learn if this study is a good match for you.

Study’s details


Contition

Heart Failure

Age

21+

Phase

N/A

Participants needed

94

Est. Completion Date

Aug 2021

Treatment type

Interventional


Sponsor

CVRx, Inc.

ClinicalTrials.gov identifier

NCT01471860

Study number

360-029

Understanding Clinical Trials


Get answers to your questions about clinical trials.What is a clinical research?What does taking part in clinical trials involve?What should I ask the trial doctor?
Vector

Interested?

Sign up to save your favorites, 
receive newsletters, resources, and alerts 
about clinical trials related to your conditions of interest.